Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3355 |
|
| Actual shortage: | 217 (6%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3128 (93%) | |
Discontinuation Reports |
359 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 335 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
61 (25%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-06-12 | 2022-05-16 | 86341 |
| APO-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-06-12 | 2019-07-02 | 86347 |
| APO-VENLAFAXINE XR | 75.0MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-06-12 | 2019-06-24 | 86364 |
| APO-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-07-17 | 2020-07-10 | 89554 |
| APO-VENLAFAXINE XR | 75.0MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-07-17 | 2019-11-25 | 89557 |
| APO-VERAP SR | 240MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2017-03-10 | 2019-12-04 | 255 |
| APO-VERAP SR | 180MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2017-03-10 | 2019-12-04 | 260 |
| APO-VERAP SR | 120MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2017-03-11 | 2019-12-04 | 552 |
| APO-VERAP TAB 80MG | 80MG | TABLET | Resolved | 2019-03-13 | 2019-04-05 | 78555 |
| APO-VERAP TAB 80MG | 80MG | TABLET | Resolved | 2023-02-23 | 2023-03-02 | 185462 |
| APO-VERAP TAB 80MG | 80MG | TABLET | Resolved | 2024-05-24 | 2024-05-31 | 228810 |
| APO-VERAP TAB 80MG | 80MG | TABLET | Resolved | 2018-05-02 | 2018-07-12 | 47972 |
| APO-VERAP TAB 80MG | 80MG | TABLET | Resolved | 2024-02-02 | 2024-04-19 | 218394 |
| APO-VERAP TAB 80MG | 80MG | TABLET | Resolved | 2023-08-12 | 2023-09-29 | 201713 |
| APO-VERAP TABLET 120MG | 120MG | TABLET | Resolved | 2023-08-18 | 2023-09-29 | 202400 |
| APO-VERAP TABLET 120MG | 120MG | TABLET | Resolved | 2023-01-06 | 2023-03-02 | 180106 |
| APO-VERAP TABLET 120MG | 120MG | TABLET | Resolved | 2019-02-24 | 2019-04-05 | 76746 |
| APO-VERAP TABLET 120MG | 120MG | TABLET | Resolved | 2019-05-29 | 2019-07-05 | 85164 |
| APO-VERAP TABLET 120MG | 120MG | TABLET | Resolved | 2019-11-13 | 2020-03-28 | 98572 |
| APO-VERAP TABLET 120MG | 120MG | TABLET | Resolved | 2024-04-12 | 2024-05-24 | 225017 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60288 |
| APO-BOSENTAN | 62.5MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71339 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71342 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2018-09-07 | 2018-10-31 | 60291 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2020-11-16 | 2020-11-16 | 128438 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | To be discontinued | 2018-09-07 | 2018-09-07 | 60294 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2018-09-07 | 2018-12-28 | 60301 |
| APO-BROMAZEPAM | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |
| APO-BROMAZEPAM | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
| APO-BROMAZEPAM | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
| APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
| APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
| APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-05-03 | 41011 |
| APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41020 |